Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer

NCT00112489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: carboplatin
DRUG: paclitaxel

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]